Total Payments
$5,012
2024 Payments
$419.16
Companies
26
Transactions
273
Medicare Patients
817
Medicare Billing
$51,380
Payment Breakdown by Category
Food & Beverage$3,536 (70.5%)
Consulting$983.33 (19.6%)
Education$465.51 (9.3%)
Travel$27.15 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,536 | 258 | 70.5% |
| Consulting Fee | $983.33 | 2 | 19.6% |
| Education | $465.51 | 12 | 9.3% |
| Travel and Lodging | $27.15 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Exeltis, USA Inc. | $1,714 | 96 | $0 (2024) |
| Allergan Inc. | $566.49 | 9 | $0 (2019) |
| Astellas Pharma US Inc | $507.96 | 13 | $0 (2024) |
| ABBVIE INC. | $380.04 | 24 | $0 (2023) |
| MAYNE PHARMA COMMERCIAL LLC | $283.89 | 24 | $0 (2023) |
| PFIZER INC. | $252.24 | 22 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $183.91 | 7 | $0 (2018) |
| Evofem Biosciences, Inc. | $166.09 | 12 | $0 (2024) |
| TherapeuticsMD, Inc. | $151.90 | 16 | $0 (2021) |
| Avion Pharmaceuticals | $126.03 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $419.16 | 26 | Exeltis, USA Inc. ($196.72) |
| 2023 | $1,214 | 69 | Astellas Pharma US Inc ($456.47) |
| 2022 | $658.53 | 55 | Exeltis, USA Inc. ($192.22) |
| 2021 | $521.14 | 46 | Exeltis, USA Inc. ($230.73) |
| 2020 | $114.48 | 9 | AbbVie Inc. ($51.02) |
| 2019 | $1,049 | 27 | Exeltis, USA Inc. ($796.26) |
| 2018 | $285.73 | 26 | PFIZER INC. ($136.91) |
| 2017 | $749.66 | 15 | Allergan Inc. ($523.63) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: CONTRACEPTIVE | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Biological | ||||||
| 12/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Biological | ||||||
| 12/02/2024 | Hologic Sales and Service, LLC | MYOSURE TISSUE REMOVAL DEVICE (Device) | Food and Beverage | In-kind items and services | $86.10 | General |
| Category: Surgical | ||||||
| 11/20/2024 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 11/13/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/30/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/16/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/15/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 09/24/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: WOMENS HEALTH | ||||||
| 09/16/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: CONTRACEPTIVE | ||||||
| 09/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Biological | ||||||
| 09/03/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: CONTRACEPTIVE | ||||||
| 08/08/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/28/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/13/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/10/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: HORMONE THERAPY | ||||||
| 05/22/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: CONTRACEPTIVE | ||||||
| 05/08/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: CONTRACEPTIVE | ||||||
| 04/17/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: CONTRACEPTIVE | ||||||
| 03/07/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $9.60 | General |
| Category: CONTRACEPTIVE | ||||||
| 03/04/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $13.26 | General |
| 02/21/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: CONTRACEPTIVE | ||||||
| 02/09/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: CONTRACEPTIVE | ||||||
| 01/24/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: CONTRACEPTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 263 | 292 | $50,775 | $11,508 |
| 2022 | 7 | 227 | 254 | $53,025 | $13,501 |
| 2021 | 7 | 182 | 208 | $52,404 | $16,462 |
| 2020 | 6 | 145 | 160 | $13,946 | $9,910 |
Total Patients
817
Total Services
914
Medicare Billing
$51,380
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 70 | $24,200 | $4,776 | 19.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 48 | 48 | $7,200 | $2,356 | 32.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 51 | 51 | $2,550 | $2,229 | 87.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $7,475 | $1,892 | 25.3% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 79 | 87 | $8,700 | $210.11 | 2.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 13 | $650.00 | $44.33 | 6.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 63 | $22,050 | $4,665 | 21.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $6,825 | $2,010 | 29.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 43 | 43 | $2,150 | $1,913 | 89.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 38 | 38 | $5,700 | $1,889 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $6,000 | $1,604 | 26.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,000 | $1,254 | 31.4% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 59 | 63 | $6,300 | $164.93 | 2.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 55 | $17,422 | $4,045 | 23.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 34 | $12,838 | $3,740 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 14 | 14 | $6,750 | $2,087 | 30.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 40 | 40 | $5,365 | $2,018 | 37.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 39 | 39 | $1,975 | $1,749 | 88.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,719 | $1,506 | 40.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $4,335 | $1,318 | 30.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 38 | 50 | $4,544 | $2,918 | 64.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 38 | 38 | $2,001 | $1,877 | 93.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 15 | 18 | $2,434 | $1,549 | 63.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 31 | 31 | $1,419 | $1,401 | 98.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $2,211 | $1,377 | 62.3% |
About Shefali Patel, MD, FACOG
Shefali Patel, MD, FACOG is a Gynecology healthcare provider based in Westfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427146596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shefali Patel, MD, FACOG has received a total of $5,012 in payments from pharmaceutical and medical device companies, with $419.16 received in 2024. These payments were reported across 273 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,536).
As a Medicare-enrolled provider, Patel has provided services to 817 Medicare beneficiaries, totaling 914 services with total Medicare billing of $51,380. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Westfield, NJ
- Active Since 10/11/2006
- Last Updated 11/28/2016
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1427146596
Products in Payments
- SLYND (Drug) $893.39
- Slynd (Drug) $718.23
- LO LOESTRIN FE (Drug) $236.49
- INTRAROSA (Drug) $202.13
- PREMARIN (Drug) $172.75
- Phexxi (Drug) $152.83
- MYFEMBREE (Drug) $145.57
- ANNOVERA (Drug) $138.21
- Orilissa (Drug) $134.16
- Veozah (Drug) $126.61
- Balcoltra (Drug) $99.75
- MYOSURE TISSUE REMOVAL DEVICE (Device) $99.23
- Vitafol Ultra (Drug) $91.13
- Twirla (Drug) $55.84
- DIVIGEL (Drug) $37.48
- Femring (Drug) $36.26
- ORILISSA (Drug) $35.79
- PVC (Drug) $33.11
- XEOMIN (Biological) $31.18
- FEMRING (Drug) $29.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.